CTX330
associated with 6 other trademarks
Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopha...

Words that describe this trademark:

disease gene therapy  treatment cardiovascular disease  gene therapy products  cardiovascular disease  pharmaceutical biopharmaceutical  clinical pharmaceutical  medical clinical  agents  cells  biopharmaceutical 

Serial Number:

97469034

Mark:

CTX330

Status:

Published for Opposition

Status Date:

04-23-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

04-23-2024

Mark Drawing Status:

4

Abandon Date:

N/A

Business Name:

233 SOUTH WACKER DRIVESUITE 6300

Recent Trademark filings by this company